Clear Filters
December 18, 2025
https://www.biocentury.com/article/657912/early-signals-stack-up-two-small-molecules-activate-gcase-in-parkinson-s
December 18, 2025
https://www.geneonline.com/two-molecules-show-potential-in-targeting-gcase-activity-for-parkinsons-disease-treatment/
December 13, 2025
https://www.the-scientist.com/ai-and-physics-based-modeling-identifies-a-new-parkinson-s-disease-drug-73851
October 9, 2025
https://www.bioworld.com/articles/724982-in-the-clinic-for-oct-9-2025
October 9, 2025
https://pharmaphorum.com/rd/allosteric-small-molecule-therapies-pd-gene-mack
October 8, 2025
https://www.ddw-online.com/early-data-suggest-gt-02287-slows-parkinsons-disease-37433-202510/
October 8, 2025
https://www.clinicaltrialvanguard.com/news/new-parkinsons-drug-gt-02287-shows-promising-phase-1b-data/
October 6, 2025
https://www.neurologylive.com/view/targeting-parkinson-pathway-abnormalities-gt-02287-jonas-hannestad
October 5, 2025
https://www.neurologylive.com/view/jonas-hannestad-phase-1b-data-gt-02287-parkinson-disease
September 26, 2025
https://www.technologynetworks.com/tn/blog/tackling-parkinsons-disease-with-allosteric-modulators-405161
September 24, 2025
https://parkinsonsnewstoday.com/news/gain-extends-trial-parkinsons-treatment-gt-02287-9-months/
September 19, 2025
https://www.clinicaltrialvanguard.com/news/gain-therapeutics-begins-promising-parkinsons-phase-1b-study/